Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018)
Stoke Therapeutics' (STOK) quarterly Net Equity Issued and Repurchased came in at $90.2 million in Q4 2018, up 574.19% quarter-over-quarter from $13.4 million in Q3 2018.
Stoke Therapeutics (STOK) Net Equity Issued and Repurchased (2018) Analysis & Trends
Stoke Therapeutics' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $90.2 million for Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 90.15 Mn |
| Dec 31, 2018 | 90.15 Mn |
| Sep 30, 2018 | 13.37 Mn |
| Sep 30, 2018 | 13.37 Mn |